Healthcare - Biotechnology - NASDAQ - US
$ 44.5
-3.8 %
$ 2.12 B
Market Cap
-19.26
P/E
INCOME STATEMENT
186 M
REVENUE
-109 M
OPERATING INCOME
-163 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Mirum Pharmaceuticals, Inc.
| Revenue | 186 M |
| Cost Of Revenue | 47 M |
| Gross Profit | 139 M |
| Operating Expenses | 248 M |
| Operating Income | -109 M |
| Other Expenses | 54.3 M |
| Net Income | -163 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 186.4 | 77.1 | 19.1 | 0 | 0 | 0 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 47.0 | 12.4 | 1.9 | 0.6 | 0.3 | 0 |
| Gross Profit | 139.3 | 64.7 | 17.2 | (0.6) | (0.3) | 0 |
| OPERATING INCOME | ||||||
| Operating Expenses | 248.5 | 195.9 | 190.6 | 104.3 | 54.7 | 2.9 |
| Selling, General and Administrative Expenses | 145.9 | 89.1 | 59.2 | 22.7 | 11.8 | 0.6 |
| Research and Development Expenses | 102.6 | 106.8 | 131.4 | 81.6 | 43.0 | 2.3 |
| Operating Income | (109.2) | (131.2) | (173.4) | (104.3) | (54.7) | (2.9) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 15.1 | 16.0 | 17.6 | 0.3 | 0 | 0 |
| Total Other Income | (53.3) | (10.9) | 89.5 | 1.0 | 2.2 | (14.4) |
| Pre-Tax Income | (162.4) | (142.1) | (84.0) | (103.3) | (52.5) | (17.3) |
| NET INCOME | ||||||
| Tax Provision | 1.0 | (6.4) | 37 K | 6 K | 21 K | (4.4) |
| Net Income | (163.4) | (135.7) | (84.0) | (103.3) | (52.6) | (17.3) |
| EPS | 4 | 4.01 | 2.77 | 4.09 | 2.29 | 0.75 |